Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.255
-0.045 (-1.05%)
Jun 3, 2026, 2:43 PM EDT - Market open
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $297.05 million as of June 3, 2026. Its market cap has decreased by -47.05% in one year.
Market Cap
297.05M
Enterprise Value
-247.09M
1-Year Change
-47.05%
Ranking
Category
Stock Price
$4.26
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $297.05M, an increase of 39.88%. That is a compound annual growth rate of 4.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 300.19M | -38.88% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 344.94M |
| Rezolute | 344.74M |
| Neumora Therapeutics | 337.97M |
| Invivyd | 335.85M |
| Rocket Pharmaceuticals | 335.22M |
| Lineage Cell Therapeutics | 331.57M |
| Fate Therapeutics | 331.03M |
| Abeona Therapeutics | 329.43M |